<DOC>
	<DOCNO>NCT01434238</DOCNO>
	<brief_summary>The purpose quasi-experimental study evaluate effectiveness infant feed intervention improve growth anemia outcome among HIV-exposed infant 6-12 month age .</brief_summary>
	<brief_title>Evaluation Infant Feeding Intervention HIV-exposed Haitian Infants</brief_title>
	<detailed_description>The need good nutrition infancy improve growth child survival outcomes well recognize especially acute context maternal human immunodeficiency virus ( HIV ) infection . WHO Guidelines Infant Feeding HIV call support HIV-infected caregiver infant feed transition across first year life . However , publish example programmatic approach effectively integrate PMTCT infant feed support service delivery level . The objective study develop test infant feed support intervention among non-breastfed HIV-exposed infant age 6-12 month enrol Prevention Mother-to-Child Transmission HIV program GHESKIO centre , HIV TB treatment clinic urban Port-au-Prince , Haiti . The investigator hypothesize growth anemia outcomes good intervention cohort compare historical control . The investigator also hypothesize infant feed support intervention feasible acceptable mother clinical staff . To accomplish objective , investigator enroll 82 HIV-exposed infant age 5.5-6.5 month recruit GHESKIO pediatric clinic 24-week intervention include ) daily ration fortify lipid-based nutrient supplement b ) nutrition counsel delivered biweekly group individualize session . Data growth , supplement use , infant feeding knowledge practice collect every 4 week intervention period . Hemoglobin dietary intake assess baseline , mid-point end intervention . Intervention child see 6-months post intervention ass growth anemia outcome . Growth anemia outcome intervention group compare medical record data same-age HIV-exposed child see GHESKIO previous year .</detailed_description>
	<mesh_term>Malnutrition</mesh_term>
	<criteria>Confirmed maternal HIVinfection Age 5.56.5 month intervention start Weightforlength zscore &gt; 3 SD ( WHO 2006 reference ) Confirmed suspect allergy peanut Participation concurrent clinical trial GHESKIO</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>infant feeding</keyword>
	<keyword>HIV</keyword>
	<keyword>growth</keyword>
	<keyword>anemia</keyword>
</DOC>